Brief: BB Biotech Q1 Net Profit At CHF 260 Mln
April 26 (Reuters) - BB BIOTECH AG BION.S :
* PRESENTS SOLID FIRST-QUARTER RESULTS; BIOTECH STOCK MARKET
IMPACTED BY SHIFTING VIEWS ON INTEREST RATES
* NET PROFIT FOR Q1 OF 2024 AMOUNTED TO CHF 260 MN (NET LOSS
OF
CHF 254 MN IN PRIOR-YEAR QUARTER)
* SIGNIFICANT NEWS FLOW IS EXPECTED OVER COURSE OF YEAR
Source text for Eikon: ID:nEQ4Vp1Vva
Further company coverage: BION.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))